首页 | 本学科首页   官方微博 | 高级检索  
检索        

国产安吖啶联合治疗急性白血病30例临床观察
引用本文:赵耀中,卞寿庚,梁彦,薛艳萍,孟庆祥,秦铁军,郭亚林,刘兵诚.国产安吖啶联合治疗急性白血病30例临床观察[J].白血病.淋巴瘤,1997(2).
作者姓名:赵耀中  卞寿庚  梁彦  薛艳萍  孟庆祥  秦铁军  郭亚林  刘兵诚
作者单位:中国医学科学院中国协和医科大学血液学研究所
摘    要:采用国产安吖啶(m-amsacrine,AMSA)联合方案治疗急性白血病(AL)30例;急性淋巴细胞白血病(ALL)6例,急性非淋巴细胞白血病(ANLL)24例;初治21例,复治9例。总的CR率为76.7%;ALL的CR率为66.6%,ANLL的CR率为79.2%,初、复治病例的CR率分别为80.9%、66.7%。主要毒性为骨髓抑制,其次为脱发、食欲下降、恶心、呕吐、口腔粘膜炎、静脉炎等。

关 键 词:安吖啶  急性白血病

ABSERVATION OF COMBINED DOMESTIC AMSACRINE FOR TREATMENT OF 30 LEUKEMIA
Zhao Yaozhong,Bian Shougen,Liang Yan,et al Haemotologic Institute Attached China Medical Acadmy,.ABSERVATION OF COMBINED DOMESTIC AMSACRINE FOR TREATMENT OF 30 LEUKEMIA[J].Journal of Leukemia & Lymphoma,1997(2).
Authors:Zhao Yaozhong  Bian Shougen  Liang Yan  Haemotologic Institute Attached China Medical Acadmy  
Abstract:Patients with acute leukemias, 6 acute lymphoblastic leukemias(ALL) and 24 acute nonlymphoblastic leukemias(ANLL), were treated with combination chemotherapy including domestic Amascrine(m AMSA). The total CR rates was 76.7%(66.6% in ALL, 79.2% in ANLL). The CR rates of previously untreated and treated patients were 80.9% and 66.7%, respectively. The chief toxicity was myelosuppression, aloecia, nausea, vomiting, mucositis and phlebitis.
Keywords:Amsacrine  Acute leukemia
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号